Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-LANSOPRAZOLE APOTEX INC Actual shortage 15MG New Report 2025-12-20 274847
APO-DULOXETINE APOTEX INC Actual shortage 30MG Updated Report 2025-12-20 274844
APO-ALFUZOSIN APOTEX INC Actual shortage 10MG New Report 2025-12-20 274841
APO-DILTIAZ CD APOTEX INC Actual shortage 180MG New Report 2025-12-20 274838
APO-ACYCLOVIR OINTMENT APOTEX INC Actual shortage 5% New Report 2025-12-20 274835
APO-CLOPIDOGREL APOTEX INC Actual shortage 75MG Updated Report 2025-12-20 274832
APO-DULOXETINE APOTEX INC Actual shortage 60MG Updated Report 2025-12-20 274829
APO-LANSOPRAZOLE APOTEX INC Resolved 30MG Updated Report 2025-12-20 272623
APO-LANSOPRAZOLE APOTEX INC Resolved 30MG Updated Report 2025-12-20 272626
APO-MYCOPHENOLIC ACID APOTEX INC Actual shortage 360MG New Report 2025-12-20 274822

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EMERADE BAUSCH HEALTH, CANADA INC. Discontinued 0.3MG Updated Report 2025-12-20 274742
EMERADE BAUSCH HEALTH, CANADA INC. Discontinued 0.5MG Updated Report 2025-12-20 274745
DILANTIN-30 SUSPENSION BGP PHARMA ULC Discontinued 30MG New Report 2025-12-19 274803
DILANTIN-125 SUSPENSION BGP PHARMA ULC Discontinued 125MG New Report 2025-12-19 274800
GRAVOL IM CHURCH & DWIGHT CANADA CORP Discontinued 50MG Updated Report 2025-12-19 274712